Skip to main content
Premium Trial:

Request an Annual Quote

TGen Begins $1.3M ALS Gene Screening With Funds From MDA

NEW YORK, March 20 (GenomeWeb News) - Translational Genomics has begun collecting 1,000 patient samples to undergo screening for variants causing ALS, or Lou Gehrig's Disease, the company said today.

 

The project is being funded with a donation of $650,000 from Augie's Quest, administered by the Muscular Dystrophy Association, and with a matching investment of $650,000 from TGen, said project director Dietrich Stephen.

 

Stephen said that the screening will be done on an Affymetrix 500K platform.

 

The samples are being collected primarily from the University of Pittsburgh, California Pacific Medical Center, Methodist Neorological Institute, and the Western ALS Group.

 

Stephen said the project will be completed by the end of 2006.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.